Journal profile · BIOLOGY

eLife

ISSN 2050-084X · eLife Sciences Publications · ENGLAND

eLife: CAS Zone 1 · Biology (2025 upgraded edition, Top journal); impact factor 5.41; fully open access; APC about USD 3,750; review about 17 weeks (community reports); 5,417 articles in 2025; indexed in ESCI and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.

Impact factor5.41Latest value listed by LetPub
CAS zoneZone 1 · Biology2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Biology
Review timeabout 17 weeksCommunity average; too few article dates (1)
APCUSD 3,750Fully open access
Acceptance—No reports yet
Articles per year5,4172025 · OpenAlex count

Scope

Aims, scope and focus

eLife is published by eLife Sciences Publications and is in Zone 1 of Biology in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Neural dynamics and brain function, Neuroscience and Neuropharmacology Research and Neurobiology and Insect Physiology Research, together about 25.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

eLife welcomes the submission of Research Articles, Short Reports, Tools and Resources articles, Research Advances, Replication Studies, Scientific Correspondence and Review Articles in the subject areas below.

From the journal's Aims & Scope

Research area (LetPub): BIOLOGY

Editor-in-chief Timothy BehrensPublisher website

Editorial board by country: 7 in mainland China (about 6%); most named United States 31, United Kingdom 21, Mainland China 7, India 7, Germany 6 (110 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Neural dynamics and brain functionNeuroscience11%
  2. Neuroscience and Neuropharmacology ResearchNeuroscience8.2%
  3. Neurobiology and Insect Physiology ResearchNeuroscience6.4%
  4. RNA Research and SplicingBiochemistry, Genetics and Molecular Biology5.8%
  5. RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology5%
  6. Memory and Neural MechanismsNeuroscience4.7%
  7. RNA modifications and cancerBiochemistry, Genetics and Molecular Biology4.4%
  8. Genomics and Chromatin DynamicsBiochemistry, Genetics and Molecular Biology4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 1
LevelCategoryZone
MajorBiologyZone 1
MinorBiologyZone 1

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Biology Zone 1
LevelCategoryZone
MajorBiologyZone 1
MinorBiologyZone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 1
LevelCategoryZone
MajorBiologyZone 1
MinorBiologyZone 1

Top journal: yesReview journal: no

Database indexing

ESCIScopusDOAJLetPub

Early warning / risk: Partly restricted in ESCI search from 16 December 2024. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub

Indexing the journal's website claims

PubMedPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
5.41LetPub ·
CiteScore 2026-06
12.9LetPub ·
SJR 2026-06
3.93LetPub ·
SNIP 2026-06
1.61LetPub ·
h-index
93LetPub ·
h-index
326OpenAlex ·
i10-index
14,766OpenAlex ·
2-year mean citedness
1.83OpenAlex ·
Share of gold OA articles
0%LetPub ·

Volume

Downloads per year (publisher)
40,000Publisher website ·

Articles by year OpenAlex count · 32,980 in total · the current year is incomplete

YearArticlesOpen accessCitations
20262,5682,568639
20255,4175,4175,914
20246,7096,70920,292
20234,1764,17648,573
20222,0392,03969,858
20212,1772,177108,636

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed

Not usableThis publisher's "received" date is mostly when the revised manuscript arrived (50% of articles were "accepted" within 3 days), so it cannot measure review time

Other sources

Average review time (community reports)
about 17 weeksLetPub ·
Submission to publication (journal-reported)
about 29 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 3,750YesCC BY, CC0
OpenAlexUSD 3,000——
LetPubUSD 3,000Yes—
Publisher websiteUSD 3,750——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare4 items from the author guidelines
Abstract
150–250 words
Suggested reviewers
Optional
Highlights
Optional
Graphical abstract
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted14, with length limits
  1. correspondenceThe publication fee applies to Research Articles, Short Reports, Tools and Resources, Research Advances, Replication Studies and Review Articles. There is not a…main text ≤ 1,500 words
  2. editorialeLife aims to provide high-quality reviews of papers that we expect to have influence in the life sciences and medicine. We are committed to improving peer revi…main text ≤ 2,000 words · references ≤ 20
  3. editorialsEditorials in eLife are written by eLife editors or staff.Length not stated
  4. feature articlesFeature Articles should offer fresh insights into topics of broad interest to readers working in the life and biomedical sciences.Length not stated
  5. insightsInsights are commissioned by eLife staff and are always related to a Research Article published in the journal.Length not stated
  6. replication studiesWe welcome Replication Studies that provide new insights into previously published research in eLife or other journals.Length not stated
  7. research advancesThis format is for articles that report developments that directly build upon a Research Article, Short Report or Tools and Resources article published previous…Length not stated
  8. research articleeLife publishes the following article types as Reviewed Preprints: Research Articles There is no maximum length for Research Articles, but we suggest that autho…main text ≤ 5,000 words
  9. research articlesThere is no maximum length for Research Articles, but we suggest that authors try not to exceed 5,000 words in the main text, excluding the Materials and method…Length not stated
  10. revieweLife publishes the following article types as Reviewed Preprints: Research Articles There is no maximum length for Research Articles, but we suggest that autho…main text ≤ 10,000 words
  11. review articleThe publication fee applies to Research Articles, Short Reports, Tools and Resources, Research Advances, Replication Studies and Review Articles. There is not a…main text ≤ 3,000 words · figures and tables ≤ 8
  12. review articlesWe are primarily interested in Review Articles that synthesize the existing knowledge in a field in an original and/or thought-provoking way, and/or that presen…Length not stated
  13. short reportsShort Reports should not usually exceed 1,500 words in the main text, excluding the Materials and Methods, References, and Figure legends, with no more than thr…Length not stated
  14. tools and resourcesTools and Resources articles should fully describe the tool or resource so that prospective users have all the information needed to deploy it within their own …Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Plagiarism, Preprints, Trial registration / reporting guidelines
AI use Use of artificial intelligence tools and technology

Generative artificial intelligence tools such as ChatGPT or AI using large language models to generate article content are at an essential level just tools as, for example, imaging or statistical software. Whilst such AI tools might be used to aid researchers and authors in doing their work, they cannot be listed as or serve as co-authors of a paper, and their use must be clearly described in the …

Source ↗Publisher website ·
Authorship Authorship

Author contributions use CRediT taxonomy. Model summary

eLife seeks to ensure that authorship is equitable, and that researchers are fairly recognised for their contributions. We recommend that all researchers who made substantial or important contributions to the design of a work, or the acquisition, analysis or interpretation of the data used in the paper, be included as authors. Authors should also ideally be involved in writing and editing the manu…

Source ↗Publisher website ·
Conflicts of interest Competing Interests and Disclosures

Competing interests must be declared for each author. Model summary

ICMJE states that the “potential for conflict of interest and bias [competing interests] exists when professional judgment concerning a primary interest (such as patients' welfare or the validity of research) may be influenced by a secondary interest (such as financial gain)”. Authors, reviewers, and editors are all required to declare any competing interests that might be perceived to interfere w…

Source ↗Publisher website ·
Data availability Data Availability

Purpose and General Principles To maintain high standards of research reproducibility, and to promote the reuse of new findings, eLife requires all data associated with an article to be made freely and widely available. These must be in the most useful formats and according to the relevant reporting standards, unless there are compelling legal or ethical reasons to restrict access. The provision o…

Source ↗Publisher website ·
Publication ethics Allegations of misconduct

If we receive an allegation of potential research or publication misconduct, we will alert those affected and ask for their response. We reserve the right to suspend the review process where necessary; to publish an expression of concern for published papers where appropriate; and/or to ask the relevant employers, or institution, or an appropriate regulatory body to investigate. If someone has con…

Source ↗Publisher website ·
License & copyright

Creative Commons Attribution license, except where otherwise noted Model summary

Subject to a Creative Commons Attribution license, except where otherwise noted.

Source ↗Publisher website ·
Plagiarism Plagiarism

As defined by COPE, plagiarism is “when somebody presents the work of others (data, words or theories) as if they were his/her own and without proper acknowledgment”, and self-plagiarism (also known as text recycling) is the “copying from author’s own work without attribution”. Manuscripts selected by eLife for peer review may be screened for plagiarism using Crossref Similarity Check (powered by …

Source ↗Publisher website ·
Preprints Reviewed Preprints

Once a preprint has been peer-reviewed by eLife, we publish a Reviewed Preprint: this includes the full text of the preprint, the eLife assessment, the public peer reviews, and (if the authors wish) a response from the authors. Reviewed Preprints will receive a DOI and eLife citation. The Reviewed Preprint will typically be posted on the eLife website within two weeks of the conclusion of the peer…

Source ↗Publisher website ·
Trial registration / reporting guidelines Clinical trial registration

eLife mandates that clinical investigators reporting phase II and phase III clinical studies must follow the CONSORT Statement for reporting of results. Submissions not in compliance with the guidelines will be returned to the authors before review. REMARK and BRISQ guidelines should be used to report studies with tumor biomarkers and human biospecimens, respectively. All clinical trials, with the…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
eLife Sciences Publications
Country or region
ENGLAND
Language
English
ISSN
2050-084X
Official links

FAQ

Frequently asked questions about eLife

What CAS zone is eLife in?

In the 2025 upgraded edition of the CAS Journal Ranking, eLife is in Zone 1 of Biology, and in Zone 1 of the minor category Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of eLife?

The latest impact factor listed by LetPub is 5.41; CiteScore 12.9, h-index 326.

How long does peer review take at eLife?

Authors report an average review time of about 17 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of eLife?

According to the journal's author guidelines: Abstract: 150–250 words; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of eLife based?

Of the 110 board members whose country the journal's board page names, 7 (about 6%) are in mainland China; the countries named most often are United States (31), United Kingdom (21) and Mainland China (7). Counted from the institutions listed on the board page; for reference only.

Which databases index eLife?

According to LetPub and DOAJ records, eLife is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.

Is eLife open access, and what is the APC?

eLife is a fully open-access journal. APC about USD 3,750.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .